February 04, 2002
1 min read
Save

Ocular surface damage may be minimized with sodium hyaluronate

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

MESSINA, Italy — Sodium hyaluronate may effectively reduce ocular surface damage associated with dry eye syndrome, according to a small study.

Researchers here conducted an efficacy analysis on 44 patients with medium to severe dry eye. Patients were treated with either one drop of preservative-free sodium hyaluronate or one drop of saline four to eight times daily for 3 months. Bulbar impression cytology, slit lamp examinations and subjective symptoms were evaluated after 1, 2 and 3 months.

Eyes treated with sodium hyaluronate had improved impression cytology scores at the 3 month mark. The difference from placebo was statistically significant (P = .036). No adverse events were reported.

The study is published in the February issue of the British Journal of Ophthalmology.